Antimicrobial resistance in community-acquired respiratory tract pathogens

Compr Ther. 1999 Jan;25(1):20-9. doi: 10.1007/BF02889831.

Abstract

Antimicrobial resistance among common respiratory pathogens has become a significant problem. However, there remain multiple treatment options, including the newer macrolides, third-generation cephalosporins, beta-lactam/beta-lactamase inhibitor antibiotics, and the newer fluoroquinolones.

Publication types

  • Review

MeSH terms

  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / microbiology*
  • Community-Acquired Infections / prevention & control
  • Drug Resistance, Microbial*
  • Europe / epidemiology
  • Haemophilus influenzae / drug effects
  • Humans
  • Moraxella catarrhalis / drug effects
  • Respiratory Tract Infections / epidemiology
  • Respiratory Tract Infections / microbiology*
  • Respiratory Tract Infections / prevention & control
  • Staphylococcus aureus / drug effects
  • Streptococcus pneumoniae / drug effects
  • United States / epidemiology